Literature DB >> 14522927

Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days.

Laura J Schild1, Rao L Divi, Frederick A Beland, Mona I Churchwell, Daniel R Doerge, Gonçalo Gamboa da Costa, M Matilde Marques, Miriam C Poirier.   

Abstract

The use of the antiestrogen tamoxifen (TAM) is associated with an increase in endometrial cancer. TAM-induced endometrial carcinogenesis may proceed through a genotoxin-mediated pathway, although the detection of endometrial TAM-DNA adducts in exposed women is still controversial. In this study, a monkey model has been used to investigate the question of TAM-DNA adduct formation in primates. Two methods have been used to determine TAM-DNA adducts: a TAM-DNA chemiluminescence immunoassay (TAM-DNA CIA), using an antiserum that has specificity for (E)-alpha-(deoxyguanosin-N(2)-yl)-tamoxifen (dG-TAM) and (E)-alpha-(deoxyguanosin-N(2)-yl)-N-desmethyltamoxifen (dG-desmethyl-TAM) and electrospray ionization tandem mass spectrometry (ES-MS/MS) coupled with on-line sample preparation and high-performance liquid chromatography (HPLC). Mature (19 year old) cynomolgus monkeys were given either vehicle control (n = 1) or TAM (n = 3) twice daily for a total dose of 2 mg of TAM/kg body weight (bw)/day for 30 days by naso-gastric intubation. Tissues were harvested, and DNA was isolated from uterus, ovary, liver, brain cortex, and kidney. By TAM-DNA CIA, values for uterine TAM-DNA adducts in two monkeys were 0.9 and 1.7 adducts/10(8) nucleotides, whereas values for ovarian TAM-DNA adducts in the same animals were 0.4 and 0.5 adducts/10(8) nucleotides. Liver, brain cortex, and kidney DNA samples from the three exposed monkeys had TAM-DNA levels of 2.1-4.2 adducts/10(8) nucleotides, 0.4-5.0 adducts/10(8) nucleotides, and 0.7-2.1 adducts/10(8) nucleotides, respectively. By HPLC-ES-MS/MS, the levels of TAM-DNA adducts detected in all tissues were comparable with those observed by TAM-DNA CIA. Thus, values for uterine TAM-DNA adducts ranged from 0.5 to 1.4 adducts/10(8) nucleotides, whereas values for ovarian TAM-DNA adducts, measurable in two monkeys, were 0.2 and 0.3 adducts/10(8) nucleotides. Liver DNA contained the highest TAM-DNA adduct levels (7.0-11.1 adducts/10(8) nucleotides), whereas brain cortex DNA contained lower adduct levels (0.6-4.8 adducts/10(8) nucleotides) and the lowest levels were measured in the kidney (0.2-0.4 adducts/10(8) nucleotides). This study indicates that cynomolgus monkeys are capable of metabolizing TAM to genotoxic intermediates that form TAM-DNA adducts in multiple tissues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522927

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Peroxidase-mediated dealkylation of tamoxifen, detected by electrospray ionization-mass spectrometry, and activation to form DNA adducts.

Authors:  Nilesh W Gaikwad; William J Bodell
Journal:  Free Radic Biol Med       Date:  2011-10-18       Impact factor: 7.376

2.  Tamoxifen-DNA adduct formation in monkey and human reproductive organs.

Authors:  Elena E Hernandez-Ramon; Nicole A Sandoval; Kaarthik John; J Mark Cline; Charles E Wood; Ruth A Woodward; Miriam C Poirier
Journal:  Carcinogenesis       Date:  2014-02-05       Impact factor: 4.944

3.  Translesion synthesis past tamoxifen-derived DNA adducts by human DNA polymerases eta and kappa.

Authors:  Manabu Yasui; Naomi Suzuki; Y R Santosh Laxmi; Shinya Shibutani
Journal:  Biochemistry       Date:  2006-10-03       Impact factor: 3.162

4.  Influence of gender on tamoxifen-induced biochemical changes in serum of rats.

Authors:  Faried Abdel-Kader El-Sayed Hemieda
Journal:  Mol Cell Biochem       Date:  2007-02-06       Impact factor: 3.842

5.  Ultrasensitive isolation, identification and quantification of DNA-protein adducts by ELISA-based RADAR assay.

Authors:  Kostantin Kiianitsa; Nancy Maizels
Journal:  Nucleic Acids Res       Date:  2014-06-09       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.